Page last updated: 2024-08-21

vancomycin and ticagrelor

vancomycin has been researched along with ticagrelor in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Goffin, E; Jacques, N; Lancellotti, P; Musumeci, L; Oury, C; Pirotte, B; Servais, L	1
Chankhamhaengdecha, S; Harnvoravongchai, P; Janvilisri, T; Ounjai, P; Phanchana, M; Phetruen, T; Raksat, P	1

Other Studies

2 other study(ies) available for vancomycin and ticagrelor

Article	Year
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria. JAMA cardiology, 2019, 06-01, Volume: 4, Issue:6 Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci	2019
Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile. Scientific reports, 2020, 04-16, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Spores, Bacterial; Ticagrelor; Vancomycin	2020

Article

Year

Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.

JAMA cardiology, 2019, 06-01, Volume: 4, Issue:6

Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci

2019

Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.

Scientific reports, 2020, 04-16, Volume: 10, Issue:1

Topics: Anti-Bacterial Agents; Biofilms; Cell Membrane; Clostridioides difficile; Clostridium Infections; Cross Infection; Drug Evaluation, Preclinical; Drug Repositioning; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Spores, Bacterial; Ticagrelor; Vancomycin

2020